ARCHITECT 7K61-37Recalls & reported problems
Abbott Ireland · ARCHITECT B12 Reagent Kit (500T) · Class 2
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00380740014193), received between Dec 5, 2020 and Nov 4, 2024 — classified as 4 malfunctions.
The most frequently reported specific device problem is “High Test Results” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- High Test Results4
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 4, 2024High Test Results; High Test Results
THE CUSTOMER REPORTED DOCTORS QUESTIONING FALSELY HIGH ARCHITECT VITAMIN B12 RESULTS FOR MULTIPLE PATIENT SAMPLES. THE CUSTOMER STATED HIGH RESULTS OF > 2000 PG/ML WERE BEING GENERATED ACROSS 2 OF THEIR ANALYZERS. THE CUSTOMER SENT THE SAMPLES OUT TO ANOTHER LAB (REFERENCE LAB) AND THE B12 RESULT OF ONE SAMPLE CAME BACK AS 285 PG/ML. THE CUSTOMER¿S REFERENCE RANGE FOR B12 IS 213-816 PG/ML. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20600937 ↗MalfunctionJun 14, 2023High Test Results; High Test Results
THE CUSTOMER REPORTED FALSELY ELEVATED ARCHITECT B12 RESULT FOR ONE PATIENT WHEN RUNNING ON THE ARCHITECT I2000SR ANALYZER. THE FOLLOWING DATA WAS PROVIDED: SID (B)(6): INITIAL B12 RESULT = 480 PG/ML; REPEAT B12 RESULTS = 265 AND 256 PG/ML THE CUSTOMER'S PROCEDURE IS TO REPEAT SAMPLES W/ RESULTS > 315 PG/ML (NORMAL REFERENCE RANGE IS 300-2000 PG/ML). THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17132158 ↗MalfunctionJan 6, 2022High Test Results; High Test Results
THE CUSTOMER REPORTED A FALSELY ELEVATED ARCHITECT B12 RESULT ON A PATIENT. RESULTS PROVIDED: (B)(6) 2021, SID (B)(6)= 364 PG/ML< REPEATED ON (B)(6) 2021 = 274 PG/ML (BOTH RESULTS USING LOT# 23108UI00). NORMAL RANGE: 345-1485 PG/ML. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13176978 ↗MalfunctionDec 5, 2020High Test Results; High Test Results
THE CUSTOMER OBSERVED A FALSELY ELEVATED ARCHITECT B12 RESULT FOR ONE PATIENT. THE FOLLOWING DATA WAS PROVIDED (CUSTOMER¿S REFERENCE RANGE IS 211-911 PG/ML): PATIENT # INITIAL RESULT, ON (B)(6) 2020, WAS 240, REPEATS WERE 197 AND 160 PG/ML. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 10951364 ↗
Other RADIOASSAY, VITAMIN B12 devices
- Access Vitamin B12 33000Beckman Coulter, Inc. · Radioassay, Vitamin B121 recall16 reports
- ADVIA Centaur® CKMB MCM 10309782Siemens Healthcare Diagnostics Inc. · RADIOASSAY, VITAMIN B121 recall0 reports
- Atellica IM VB12 10995715Siemens Healthcare Diagnostics Inc. · RADIOASSAY, VITAMIN B1224 reports
- Elecsys Vitamin B12 II 07028121190Roche Diagnostics GmbH · RADIOASSAY, VITAMIN B1221 reports
- Atellica IM VB12 10995714Siemens Healthcare Diagnostics Inc. · RADIOASSAY, VITAMIN B1213 reports
- ADVIA Centaur® VB12 10309970Siemens Healthcare Diagnostics Inc. · RADIOASSAY, VITAMIN B128 reports
- ARCHITECT 7K61-27Abbott Ireland · RADIOASSAY, VITAMIN B123 reports
- Alinity 09P2635Abbott GmbH · Radioassay, vitamin b121 report
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.